Demembranated skeletal and cardiac fibers produce less force with altered cross-bridge kinetics in a mouse model for limb-girdle muscular dystrophy 2i

2019 ◽  
Vol 317 (2) ◽  
pp. C226-C234
Author(s):  
Axel J. Fenwick ◽  
Peter O. Awinda ◽  
Jacob A. Yarbrough-Jones ◽  
Jennifer A. Eldridge ◽  
Buel D. Rodgers ◽  
...  

Limb-girdle muscular dystrophy 2i (LGMD2i) is a dystroglycanopathy that compromises myofiber integrity and primarily reduces power output in limb muscles but can influence cardiac muscle as well. Previous studies of LGMD2i made use of a transgenic mouse model in which a proline-to-leucine (P448L) mutation in fukutin-related protein severely reduces glycosylation of α-dystroglycan. Muscle function is compromised in P448L mice in a manner similar to human patients with LGMD2i. In situ studies reported lower maximal twitch force and depressed force-velocity curves in medial gastrocnemius (MG) muscles from male P448L mice. Here, we measured Ca2+-activated force generation and cross-bridge kinetics in both demembranated MG fibers and papillary muscle strips from P448L mice. Maximal activated tension was 37% lower in MG fibers and 18% lower in papillary strips from P448L mice than controls. We also found slightly faster rates of cross-bridge recruitment and detachment in MG fibers from P448L than control mice. These increases in skeletal cross-bridge cycling could reduce the unitary force output from individual cross bridges by lowering the ratio of time spent in a force-bearing state to total cycle time. This suggests that the decreased force production in LGMD2i may be due (at least in part) to altered cross-bridge kinetics. This finding is notable, as the majority of studies germane to muscular dystrophies have focused on sarcolemma or whole muscle properties, whereas our findings suggest that the disease pathology is also influenced by potential downstream effects on cross-bridge behavior.

1987 ◽  
Vol 65 (8) ◽  
pp. 1798-1801 ◽  
Author(s):  
J. M. Renaud ◽  
R. B. Stein ◽  
T. Gordon

Changes in force and stiffness during contractions of mouse extensor digitorum longus and soleus muscles were measured over a range of extracellular pH from 6.4 to 7.4. Muscle stiffness was measured using small amplitude (<0.1% of muscle length), high frequency (1.5 kHz) oscillations in length. Twitch force was not significantly affected by changes in pH, but the peak force during repetitive stimulation (2, 3, and 20 pulses) was decreased significantly as the pH was reduced. Changes in muscle stiffness with pH were in the same direction, but smaller in extent. If the number of attached cross-bridges in the muscle can be determined from the measurement of small amplitude, high frequency muscle stiffness, then these findings suggest that (a) the number of cross-bridges between thick and thin filaments declines in low pH and (b) the average force per cross-bridge also declines in low pH. The decline in force per cross-bridge could arise from a reduction in the ability of cross-bridges to generate force during their state of active force production and (or) in an increased percentage of bonds in a low force, "rigor" state.


2021 ◽  
Vol 129 (Suppl_1) ◽  
Author(s):  
Rohit Singh ◽  
Sakthivel Sadayappan

Rationale: Normal heart function depends on cardiac myosin binding protein-C (cMyBP-C) phosphorylation. Its decrease is associated with heart failure (HF) by inhibiting actomyosin interactions. In absence of cMyBP-C phosphorylation, the protein is bound to myosin S2, but released when phosphorylated, allowing myosin to form cross-bridges with actin. Challenging cMyBP-C/myosin S2 interaction by myopeptide (the first 126 amino acids of myosin S2) could promote actomyosin interaction in vitro , but its ability to improve contractility in HF remains untested. Objective: To test contractile function in skinned papillary fibers of a cMyBP-C dephosphorylated mouse model using myopeptide. Methods and Results: To mimic constitutive phosphoablation, a knock-in mouse model was established to express cMyBP-C in which serines 273, 282 and 302 were mutated to alanine (cMyBP-C AAA ). Western blotting revealed 50% and 100% of cMyBP-C AAA in het and homo mouse hearts, respectively. Echocardiography showed a decreased percentage of ejection fraction (28%, p<0.01) and fractional shortening (30%, p< 0.05) in both het and homo cMyBP-C AAA mice at 3 months of age, compared to knock-in negative controls. These mice also developed diastolic dysfunction with elevated ratio of E/A and E/e’ waves. Next, pCa-force measurements using skinned papillary fibers determined that maximal force (F max ) and rate of cross-bridge formation ( k tr ) were decreased in the cMyBP-C AAA groups, compared to the control. However, administration of dose-dependent myopeptide increased F max and k tr in wild-type and cMyBP-C AAA permeabilized skinned papillary fibers without affecting myofilament Ca 2+ sensitivity. Conclusions: Myopeptide can increase contractile force and rate of cross-bridge formation by releasing cMyBP-C/myosin S2 and promoting actomyosin formation of cross-bridges, thus validating its therapeutic potential.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Karim Azzag ◽  
Carolina Ortiz-Cordero ◽  
Nelio A. J. Oliveira ◽  
Alessandro Magli ◽  
Sridhar Selvaraj ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Marino DiFranco ◽  
Irina Kramerova ◽  
Julio L. Vergara ◽  
Melissa Jan Spencer

2002 ◽  
Vol 282 (4) ◽  
pp. C647-C653 ◽  
Author(s):  
Jeffrey J. Widrick

Chemically skinned muscle fibers, prepared from the rat medial gastrocnemius and soleus, were subjected to four sequential slack tests in Ca2+-activating solutions containing 0, 15, 30, and 0 mM added Pi. Pi (15 and 30 mM) had no effect on the unloaded shortening velocity ( V o) of fibers expressing type IIb myosin heavy chain (MHC). For fibers expressing type I MHC, 15 mM Pi did not alter V o, whereas 30 mM Pireduced V o to 81 ± 1% of the original 0 mM Pi value. This effect was readily reversible when Pi was lowered back to 0 mM. These results are not compatible with current cross-bridge models, developed exclusively from data obtained from fast fibers, in which V o is independent of Pi. The response of the type I fibers at 30 mM Pi is most likely the result of increased internal drag opposing fiber shortening resulting from fiber type-specific effects of Pi on cross bridges, the thin filament, or the rate-limiting step of the cross-bridge cycle.


2014 ◽  
Vol 22 (11) ◽  
pp. 1890-1899 ◽  
Author(s):  
Chunping Qiao ◽  
Chi-Hsien Wang ◽  
Chunxia Zhao ◽  
Peijuan Lu ◽  
Hiroyuki Awano ◽  
...  

2008 ◽  
Vol 33 (3) ◽  
pp. 518-526 ◽  
Author(s):  
Cornelis J. de Ruiter ◽  
Tinelies E. Busé-Pot ◽  
Arnold de Haan

During many movements (e.g., running, jumping, and kicking) there is little time for skeletal muscles to build up force, thus rapid force development is important. The length dependency of isometric force development was investigated in maximally activated rat medial gastrocnemius muscles in situ with intact blood flow at 35 °C. Depending on time available for muscle activation, the length dependency of force development was expected to differ from that of the maximal isometric force (Fmax) reached much later during the contraction. During isometric force development in intact muscle–tendon preparations, the contractile elements actually shortened. Therefore, similar to previous findings on shortening contractions, it was hypothesized that maximal rate of force development (MRFD) would be obtained at a length below the optimum (Lo) for maximal isometric force production. To measure the effect of the entire time history of activation, force time integrals (FTIs) for different activation times (10–50 ms) were also calculated. The highest MRFD was obtained 1.94 ± 0.42 mm below (p < 0.05) Lo. When expressed relative to Fmax obtained at each individual length, the optimum was found at Lo – 4.4 mm. For FTI 10 ms and FTI 20 ms, optimum length was obtained at ~2 and 1 mm above (p < 0.05) Lo, respectively, whereas the optima for FTI 30, 40, and 50 ms were ~1 mm below (p < 0.05) Lo. In addition, at short lengths (< Lo – 4 mm) and for all activation times FTIs were relatively more decreased than Fmax. In conclusion, length dependency of force output during rapid force development differed from that of maximal isometric force; specifically, MRFD was obtained 2 mm below Lo.


2009 ◽  
Vol 175 (6) ◽  
pp. 2299-2308 ◽  
Author(s):  
Thomas H. Chase ◽  
Gregory A. Cox ◽  
Lisa Burzenski ◽  
Oded Foreman ◽  
Leonard D. Shultz

1998 ◽  
Vol 274 (5) ◽  
pp. C1306-C1311 ◽  
Author(s):  
C. Y. Seow ◽  
L. Morishita ◽  
B. H. Bressler

Direct action of the cardiotonic bipyridine milrinone on the cross bridges of single fibers of skinned rabbit skeletal muscle was investigated. At 10°C and pH 7.0, milrinone reduced isometric tension in a logarithmically concentration-dependent manner, with a 55% reduction in force at 0.6 mM. Milrinone also reduced Ca2+ sensitivity of skinned fibers in terms of force production; the shift in the force-pCa curve indicated a change in the pCa value at 50% maximal force from 6.10 to 5.94. The unloaded velocity of shortening was reduced by 18% in the presence of 0.6 mM milrinone. Parts of the transient tension response to step change in length were altered by milrinone, so that the test and control transients could not be superimposed. The results indicate that milrinone interferes with the cross-bridge cycle and possibly detains cross bridges in low-force states. The results also suggest that the positive inotropic effect of milrinone on cardiac muscle is probably not due to the drug’s direct action on the muscle cross bridges. The specific and reversible action of the bipyridine on muscle cross bridges makes it a potentially useful tool for probing the chemomechanical cross-bridge cycle.


Sign in / Sign up

Export Citation Format

Share Document